comparemela.com

Latest Breaking News On - Albert kildani - Page 1 : comparemela.com

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q3 2023 Earnings Call Transcript

Operator: Good day ladies and gentlemen and welcome to ACADIA Pharmaceuticals Third Quarter 2023 Financial Results Conference Call. My name is Kathy and I will be your coordinator for today.

United-states
Canada
Parag-meswani
Gregory-renza
Brendan-teehan
Albert-kildani
Yatin-suneja
Tessa-romero
Mark-schneyer
Doug-williamson
Kathie-bishop
Al-kildani

Acadia Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operating Overview

Acadia Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operating Overview
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United-states
American
Steve-davis
Acadia-pharmaceuticals-reports-third-quarter
Exchange-commission
Neuren-pharmaceuticals
Nasdaq
Acadia-executive-management-committee
Twitter
Linkedin
Acadia-pharmaceuticals
Corporate-communications

Arcadia appoints new vice president of IR

San Diego-headquartered pharmaceutical company Arcadia has named Albert Kildani as its new senior vice president of IR and corp

Albert-kildani
Mark-schneyer
San-diego-headquartered
Halozyme-therapeutics
Vital-therapies
Wall-street
Ir-magazine
Conomist-group
Publication
Reporting
Events

Acadia Pharmaceuticals Appoints Albert Kildani as Senior Vice President, Investor Relations and Corporate Communications

Acadia Pharmaceuticals Inc. today announced the appointment of Albert Kildani as Senior Vice President, Investor Relations and Corporate Communications. Mr. Kildani will be responsible for leading.

Mark-schneyer
Acadia-pharmaceuticals
Boston-college
Hologic-inc
Exchange-commission
Corporate-communications
Linkedin
Vital-therapies-inc
Twitter
Nasdaq
Acadia-pharmaceuticals-inc

vimarsana © 2020. All Rights Reserved.